TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy
| Image |  |
|---|---|
| Description | scientific article published on 22 February 2016 |
| Author/s |
author: Kathy A Fuller Wendy Erber Deborah L. White John Reynolds Angel F. Lopez Timothy Hughes |
| Publication date | February 22, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |